9
NMR (600 MHz, CDCl3): δ 8.07 (br, s, 1H), 7.45 (d, J = 7.8 Hz,
1H), 7.07 (dd, J = 7.8, 7.2 Hz, 1H), 7.02 (d, J = 7.2 Hz, 1H), 6.98
(s, 1H), 5.98 (s, 1H), 2.99 (t, J = 7.8 Hz, 2H), 2.65 (t, J = 7.8 Hz,
2H), 2.49 (s, 3H), 2.38 (dd, J = 6.6, 6.6 Hz, 2H), 2.34 (dd, J =
6.0, 6.0 Hz, 2H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR
(150 MHz, CDCl3): δ 200.2, 166.5, 136.0, 126.8, 126.0, 122.7,
121.1, 120.6, 119.6, 116.4, 115.6, 38.6, 37.5, 30.0, 23.2, 22.8,
16.7. HRMS (ESI) calcd. for C17H20NO+ [M+H]+ 254.1539,
found 254.1560.
1H), 7.01 (d, J = 1.8 Hz, 1H), 6.95 (s, 1H), 6.87 (dd, J = 8.4,
ACCEPTED MANUSCRIPT
1.8 Hz, 1H), 5.98 (s, 1H), 3.87 (s, 3H), 2.94 (t, J = 7.8 Hz, 2H),
2.63 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.33 (dd,
J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13
C
NMR (150 MHz, CDCl3): δ 200.2, 166.5, 154.0, 131.6, 127.6,
126.0, 122.2, 114.7, 122.2, 112.1, 100.7, 56.1, 38.3, 37.4, 30.0,
23.0, 22.8. HRMS (ESI) calcd. for C17H20NO2 [M+H]+
+
270.1589, found 270.1490.
5.5.13. 3-(2-(7-methoxy-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one
(5m). Synthesized according to the general procedure and
purified by flash column chromatography (hexanes/ethyl acetate
= 80:20 to 70:30) to yield a white solid (65.4 mg, 0.243 mmol,
5.5.8.
3-(2-(5-cyano-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one
(5h). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 60:40
1
1
to 50:50) to yield a white solid (42.0 mg, 0.159 mmol, 40%). H
61%). H NMR (600 MHz, CDCl3): δ 8.30 (br, s, 1H), 7.19 (d, J
NMR (600 MHz, CDCl3): δ 8.41 (br, s, 1H), 7.93 (s, 1H), 7.44-
7.41 (m, 2H), 7.11 (d, J = 2.4 Hz, 1H), 5.91 (s, 1H), 2.98 (t, J =
7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz,
2H), 2.34 (dd, J = 6.0, 6.0 Hz, 2H), 2.00 (ddd, J = 13.2, 6.6, 6.0
Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.0, 165.3, 138.1,
127.2, 126.3, 125.3, 124.5, 123.6, 120.8, 116.2, 112.3, 102.7,
38.3, 37.5, 29.9, 22.8, 22.6. HRMS (ESI) calcd. for C17H17N2O+
[M+H]+ 265.1335, found 265.1343.
= 7.8 Hz, 1H), 7.05 (dd, J = 7.8, 7.8 Hz, 1H), 6.95 (s, 1H), 6.66
(d, J = 7.8 Hz, 1H), 5.98 (s, 1H), 3.96 (s, 3H), 2.97 (t, J = 7.8 Hz,
2H), 2.63 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.32
(dd, J = 6.0, 6.0 Hz, 2H), 1.98 (ddd, J = 12.6, 6.6, 6.0 Hz, 2H).
13C NMR (150 MHz, CDCl3): δ 200.1, 166.4, 146.3, 128.6,
126.9, 126.0, 121.0, 119.8, 115.5, 111.4, 102.0, 55.4, 38.6, 37.4,
+
29.9, 23.2, 22.8. HRMS (ESI) calcd. for C17H20NO2 [M+H]+
270.1589, found 270.1507.
5.5.9.
3-(2-(7-cyano-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one
5.5.14. 3-(2-(5-methyl-1H-pyrrol-2-yl)ethyl)cyclohex-2-en-1-one
(5n). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 80:20
to 70:30) to yield a yellow solid (54.2 mg, 0.266 mmol, 67%). 1H
NMR (600 MHz, CDCl3): δ 7.78 (br, s, 1H), 5.92 (s, 1H), 5.79-
5.78 (m, 1H), 5.76-5.75 (m, 1H), 2.77 (t, J = 7.8 Hz, 2H), 2.54 (t,
J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.30 (dd, J = 6.0,
6.0 Hz, 2H), 2.24 (s, 3H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H).
13C NMR (150 MHz, CDCl3): δ 200.0, 165.7, 129.4, 126.7,
125.9, 106.0, 105.5, 38.1, 37.5, 30.0, 25.5, 22.8, 13.1. HRMS
(5i). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 60:40
to 50:50) to yield a white solid (49.6 mg, 0.188 mmol, 47%). H
1
NMR (600 MHz, CDCl3): δ 8.27 (br, s, 1H), 7.51 (d, J = 7.8 Hz,
1H), 7.35 (d, J = 7.8 Hz, 1H), 7.04 (s, 1H), 7.01 (dd, J = 7.8, 7.8
Hz, 1H), 5.96 (s, 1H), 2.96 (t, J = 7.8 Hz, 2H), 2.62 (t, J = 7.8
Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.31 (dd, J = 6.0, 6.0 Hz,
2H), 1.98 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz,
CDCl3): 200.0, 165.9, 141.2, 135.1, 128.5, 126.1, 124.6, 122.0,
120.6, 118.0, 116.5, 105.0, 38.4, 37.5, 30.0, 23.1, 22.8. HRMS
(ESI) calcd. for C17H17N2O+ [M+H]+ 265.1335, found 265.1355.
+
(ESI) calcd. for C14H21O2 [M+H]+ 221.1536, found 221.1539.
HRMS (ESI) calcd. for C13H18NO+ [M+H]+ 204.1383, found
204.1394
5.5.10.
3-(2-(5-bromo-1H-indol-3-yl)ethyl)cyclohex-2-en-1one
(5j). Synthesized according to the general procedure and purified
5.5.15. 3-(2-(5-methoxythiophen-2-yl)ethyl)cyclohex-2-en-1-one
(5o). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 80:20
by flash column chromatography (hexanes/ethyl acetate = 80:20
1
to 70:30) to yield a white solid (72.0 mg, 0.226 mmol, 57%). H
1
NMR (600 MHz, CDCl3): δ 8.24 (br, s, 1H), 7.69 (s, 1H), 7.26
(dd, J = 8.4, 1.2 Hz, 1H), 7.22 (d, J = 8.4 Hz, 1H), 6.97 (s, 1H),
5.93 (s, 1H), 2.92 (t, J = 7.8 Hz, 2H), 2.60 (t, J = 7.8 Hz, 2H),
2.37 (dd, J = 6.6, 6.6, Hz, 2H), 2.32 (dd, J = 6.0, 6.0 Hz, 2H),
1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (100 MHz,
CDCl3): δ 200.1, 165.9, 135.0, 129.1, 126.2, 125.1, 122.7, 121.4,
114.9, 112.83, 112.78, 38.4, 37.5, 30.0, 22.84, 22.83. HRMS
(ESI) calcd. for C16H17BrNO+ [M+H]+ 318.0488, found
318.0506.
to 70:30) to yield a yellow oil (46.3 mg, 0.196 mmol, 49%). H
NMR (600 MHz, CDCl3): δ 6.37 (d, J = 3.6 Hz, 1H), 5.97 (d, J =
3.6 Hz, 1H), 5.89 (s, 1H), 3.84 (s, 3H), 2.88 (t, J = 7.8 Hz, 2H),
2.52 (t, J = 7.8 Hz, 2H), 2.35 (dd, J = 6.6, 6.6 Hz, 2H), 2.29 (dd,
J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C
NMR (150 MHz, CDCl3): δ 199.8, 164.6, 164.5, 129.5, 126.4,
121.7, 103.1, 60.3, 39.8, 37.5, 29.9, 28.1, 22.8. HRMS (ESI)
calcd. for C13H17O2S+ [M+H]+ 237.0944, found 237.0957.
5.5.16. 3-(2-(4,5-dimethylfuran-2-yl)ethyl)cyclohex-2-en-1-one
(5p). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 80:20
to 70:30) to yield a colorless oil (41.9 mg, 0.192 mmol, 48%). 1H
NMR (600 MHz, CDCl3): δ 5.88 (s, 1H), 5.76 (s, 1H), 2.74 (t, J =
7.8 Hz, 2H), 2.51 (t, J = 7.8 Hz, 2H), 2.35 (dd, J = 6.6, 6.6 Hz,
2H), 2.28 (dd, J = 6.0, 6.0 Hz, 2H), 2.14 (s, 3H), 1.98 (ddd, J =
13.2, 6.6, 6.0 Hz, 2H), 1.87 (s, 3H). 13C NMR (150 MHz,
CDCl3): δ 199.9, 165.2, 151.2, 145.9, 126.1, 114.4, 108.8, 37.5,
36.6, 29.8, 25.7, 22.8, 11.4, 10.0. HRMS (ESI) calcd. for
C14H19O2+ [M+H]+ 219.1380, found 219.1388.
5.5.11. 3-(2-(7-bromo-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one
(5k). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 80:20
1
to 70:30) to yield a white solid (61.8 mg, 0.194 mmol, 49%). H
NMR (600 MHz, CDCl3): δ 8.35 (br, s, 1H), 7.68 (s, 1H), 7.25
(d, J = 8.4 Hz, 1H), 7.21 (d, J = 8.4 Hz, 1H), 6.96 (s, 1H), 5.93
(s, 1H), 2.91 (t, J = 7.8 Hz, 2H), 2.59 (t, J = 7.8 Hz, 2H), 2.37
(dd, J = 6.6, 6.6 Hz, 2H), 2.32 (6.0, 6.0 Hz, 2H), 1.98 (ddd, J =
12.6, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.2,
166.2, 135.0, 129.0, 126.1, 124.9, 122.8, 121.3, 114.7, 112.9,
112.6, 38.4, 37.4, 29.9, 22.8, 22.8. HRMS (ESI) calcd. for
C16H17BrNO+ [M+H]+ 318.0488, found 318.0505.
5.6. Experimental procedure for competition experiments
5.6.1. A competition experiment for generating heteroarylated
products 3d and 5a was carried out by the following procedure.
To a 1 dram vial was added Bi(OTf)3 (4.1 mg, 0.0063 mmol,
0.025 equiv) indole (29.3 mg, 0.25 mmol), 3-methyl-2-
cyclohexenone (55.1 mg, 0.500 mmol), 3-vinyl-2-cyclohexenone
(61.3 mg, 0.500 mmol), and acetonitrile/methanol (10:1) solution
5.5.12. 3-(2-(5-methoxy-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one
(5l). Synthesized according to the general procedure and purified
by flash column chromatography (hexanes/ethyl acetate = 80:20
to 70:30) to yield a white solid (68.9 mg, 0.256 mmol, 64%). H
NMR (600 MHz, CDCl3): δ 8.13 (br, s, 1H), 7.24 (d, J = 8.4 Hz,
1